company background image

JEOL TSE:6951 Stock Report

Last Price


Market Cap







26 Sep, 2022


Company Financials +
6951 fundamental analysis
Snowflake Score
Future Growth3/6
Past Performance5/6
Financial Health6/6

6951 Stock Overview

JEOL Ltd. engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment.

JEOL Competitors

Price History & Performance

Summary of all time highs, changes and price drops for JEOL
Historical stock prices
Current Share PriceJP¥4,965.00
52 Week HighJP¥9,840.00
52 Week LowJP¥4,940.00
1 Month Change-13.95%
3 Month Change-7.37%
1 Year Change-43.13%
3 Year Change88.21%
5 Year Change338.60%
Change since IPO218.27%

Recent News & Updates

Shareholder Returns

6951JP Medical EquipmentJP Market

Return vs Industry: 6951 underperformed the JP Medical Equipment industry which returned -21.1% over the past year.

Return vs Market: 6951 underperformed the JP Market which returned -9.1% over the past year.

Price Volatility

Is 6951's price volatile compared to industry and market?
6951 volatility
6951 Average Weekly Movement4.8%
Medical Equipment Industry Average Movement4.0%
Market Average Movement3.5%
10% most volatile stocks in JP Market7.4%
10% least volatile stocks in JP Market1.9%

Stable Share Price: 6951 is not significantly more volatile than the rest of JP stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 6951's weekly volatility (5%) has been stable over the past year.

About the Company

19493,291Izumi Oi

JEOL Ltd. engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment. The company provides transmission electron microscopes; scanning electron microscopes; ion beam application equipment, including specimen preparation equipment and multibeam systems; instruments for micro area and surface analysis, such as electron probe micro analyzers, auger microprobes, and photoelectron spectrometers; magnetic resonance equipment, such as nuclear magnetic resonance and electron spin resonance spectrometers; X-ray fluorescence spectrometers; mass spectrometers; electron beam lithography systems; and clinical chemistry analyzers. It also offers industrial equipment for thin-film formation and material processing, including thin film formation equipment and material processing equipment.

JEOL Fundamentals Summary

How do JEOL's earnings and revenue compare to its market cap?
6951 fundamental statistics
Market CapJP¥253.33b
Earnings (TTM)JP¥14.73b
Revenue (TTM)JP¥143.47b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
6951 income statement (TTM)
Cost of RevenueJP¥85.55b
Gross ProfitJP¥57.92b
Other ExpensesJP¥43.19b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Nov 11, 2022

Earnings per share (EPS)288.69
Gross Margin40.37%
Net Profit Margin10.27%
Debt/Equity Ratio17.2%

How did 6951 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio

Does 6951 pay a reliable dividends?

See 6951 dividend history and benchmarks
When do you need to buy 6951 by to receive an upcoming dividend?
JEOL dividend dates
Ex Dividend DateSep 29 2022
Dividend Pay DateDec 06 2022
Days until Ex dividend2 days
Days until Dividend pay date70 days

Does 6951 pay a reliable dividends?

See 6951 dividend history and benchmarks
We’ve recently updated our valuation analysis.


Is 6951 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 3/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6951?

Other financial metrics that can be useful for relative valuation.

6951 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.6x
Enterprise Value/EBITDA11.5x
PEG Ratio1.5x

Price to Earnings Ratio vs Peers

How does 6951's PE Ratio compare to its peers?

6951 PE Ratio vs Peers
The above table shows the PE ratio for 6951 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average13.4x
6849 Nihon Kohden
7716 Nakanishi
7817 Paramount Bed Holdings
6960 Fukuda Denshi
6951 JEOL

Price-To-Earnings vs Peers: 6951 is expensive based on its Price-To-Earnings Ratio (17.2x) compared to the peer average (13.4x).

Price to Earnings Ratio vs Industry

How does 6951's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

Price-To-Earnings vs Industry: 6951 is expensive based on its Price-To-Earnings Ratio (17.2x) compared to the JP Medical Equipment industry average (14.5x)

Price to Earnings Ratio vs Fair Ratio

What is 6951's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6951 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.2x
Fair PE Ratio25.8x

Price-To-Earnings vs Fair Ratio: 6951 is good value based on its Price-To-Earnings Ratio (17.2x) compared to the estimated Fair Price-To-Earnings Ratio (25.8x).

Share Price vs Fair Value

What is the Fair Price of 6951 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6951 (¥4965) is trading below our estimate of fair value (¥9936.78)

Significantly Below Fair Value: 6951 is trading below fair value by more than 20%.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

Future Growth

How is JEOL forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score


Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6951's forecast earnings growth (11.8% per year) is above the savings rate (0.04%).

Earnings vs Market: 6951's earnings (11.8% per year) are forecast to grow faster than the JP market (8.4% per year).

High Growth Earnings: 6951's earnings are forecast to grow, but not significantly.

Revenue vs Market: 6951's revenue (6.2% per year) is forecast to grow faster than the JP market (4.2% per year).

High Growth Revenue: 6951's revenue (6.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 6951's Return on Equity is forecast to be low in 3 years time (18.5%).

Discover growth companies

Past Performance

How has JEOL performed over the past 5 years?

Past Performance Score


Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 6951 has high quality earnings.

Growing Profit Margin: 6951's current net profit margins (10.3%) are higher than last year (3.9%).

Past Earnings Growth Analysis

Earnings Trend: 6951's earnings have grown significantly by 21.5% per year over the past 5 years.

Accelerating Growth: 6951's earnings growth over the past year (235.3%) exceeds its 5-year average (21.5% per year).

Earnings vs Industry: 6951 earnings growth over the past year (235.3%) exceeded the Medical Equipment industry 3.7%.

Return on Equity

High ROE: 6951's Return on Equity (16.7%) is considered low.

Discover strong past performing companies

Financial Health

How is JEOL's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 6951's short term assets (¥145.4B) exceed its short term liabilities (¥76.3B).

Long Term Liabilities: 6951's short term assets (¥145.4B) exceed its long term liabilities (¥20.9B).

Debt to Equity History and Analysis

Debt Level: 6951 has more cash than its total debt.

Reducing Debt: 6951's debt to equity ratio has reduced from 74% to 17.2% over the past 5 years.

Debt Coverage: 6951's debt is well covered by operating cash flow (148.5%).

Interest Coverage: 6951 earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies


What is JEOL current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


Current Dividend Yield

Upcoming Dividend Payment

TodaySep 27 2022Ex Dividend DateSep 29 2022Dividend Pay DateDec 06 202268 days from Ex DividendBuy in the next 2 days to receive the upcoming dividend

Dividend Yield vs Market

JEOL Dividend Yield vs Market
How does JEOL dividend yield compare to the market?
SegmentDividend Yield
Company (JEOL)1.2%
Market Bottom 25% (JP)1.7%
Market Top 25% (JP)3.7%
Industry Average (Medical Equipment)1.0%
Analyst forecast in 3 Years (JEOL)1.5%

Notable Dividend: 6951's dividend (1.21%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.65%).

High Dividend: 6951's dividend (1.21%) is low compared to the top 25% of dividend payers in the JP market (3.67%).

Stability and Growth of Payments

Stable Dividend: 6951's dividend payments have been volatile in the past 10 years.

Growing Dividend: 6951's dividend payments have increased over the past 10 years.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (17.1%), 6951's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (14.5%), 6951's dividend payments are thoroughly covered by cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Izumi Oi



Mr. Izumi Oi is President of JEOL Ltd. since June 2019 and served as its Chief Operating Officer since June 2019 until 2022. He was an Executive Officer at Jeol Ltd.until June 2019 and served as its Corpo...

Leadership Team

Experienced Management: 6951's management team is considered experienced (3.3 years average tenure).

Board Members

Experienced Board: 6951's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 6951?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders80,1000.2%
Employee Share Scheme2,046,0004.0%
Public Companies2,300,0004.5%
General Public22,011,37543.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 53.73% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
Sumitomo Mitsui Trust Asset Management Co., Ltd.
Nikon Corporation
2,300,000¥11.4b0%no data
Sumitomo Mitsui DS Asset Management Company, Limited
Artisan Partners Limited Partnership
Mitsubishi UFJ Trust and Banking Corporation, Asset Management Arm
The Vanguard Group, Inc.
1,366,877¥6.8b1.32%no data
Nomura Asset Management Co., Ltd.
MUFG Bank, Ltd.,Investment Banking Arm
Jeol, Ltd., Mutual Prosperity Association
1,120,000¥5.6b0%no data
Nissay Asset Management Corporation
Jeol Ltd. ESOP
926,000¥4.6b0%no data
Baillie Gifford & Co.
BlackRock, Inc.
789,807¥3.9b0.11%no data
Norges Bank Investment Management
639,829¥3.2b0%no data
Nikko Asset Management Co., Ltd.
Jupiter Fund Management Plc
Daiwa Asset Management Co. Ltd.
Rheos Capital Works, Inc.
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
Massachusetts Financial Services Company
247,810¥1.2b0.07%no data
Sumitomo Mitsui Financial Group Inc., Asset Management Arm
abrdn plc
WCM Investment Management, LLC
American Century Investment Management Inc

Company Information

JEOL Ltd.'s employee growth, exchange listings and data sources

Key Information

  • Name: JEOL Ltd.
  • Ticker: 6951
  • Exchange: TSE
  • Founded: 1949
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: JP¥253.330b
  • Shares outstanding: 51.02m
  • Website:

Number of Employees


  • JEOL Ltd.
  • 3-1-2, Musashino
  • Akishima
  • Tokyo
  • 196-8558
  • Japan


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
JELL.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJan 1992
6951TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYJan 1992
JELDB (Deutsche Boerse AG)YesCommon StockDEEURJan 1992

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/26 00:00
End of Day Share Price2022/09/26 00:00
Annual Earnings2022/03/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.